MENOPAUSE IS ASSOCIATED WITH RELAPSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN

被引:0
|
作者
Stern, Christiane [1 ]
Martinot-Peignoux, Michelle [1 ]
Ripault, Marie-Pierre [1 ]
Boyer, Nathalie [1 ]
Cardoso, Ana Carolina [1 ]
El Ray, Ahmed [1 ]
Asselah, Tarik [1 ]
Valla, Dominique [1 ]
Marcellin, Patrick [1 ]
机构
[1] Hop Beaujon, Serv Hepatol, Clichy, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
969
引用
收藏
页码:788A / 788A
页数:1
相关论文
共 50 条
  • [1] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    [J]. Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [2] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Trapero-Marugan, M.
    Garcia-Buey, L.
    Munoz, C.
    Moreno-Monteagudo, J. A.
    Borque, M. J.
    Salcedo-Mora, X.
    Moreno-Otero, R.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S227 - S228
  • [3] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Marugán, MT
    Moreno-Otero, R
    Garcia-Buey, L
    Moreno-Monteagudo, JA
    Vitón, M
    Muñoz, C
    Borque, MJ
    Salcedo-Mora, X
    [J]. HEPATOLOGY, 2005, 42 (04) : 668A - 668A
  • [4] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [5] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    [J]. HEPATITIS MONTHLY, 2013, 13 (12)
  • [6] Impact of Ribavirin Dosage in Chronic Hepatitis C Patients Treated With Simeprevir, Pegylated Interferon Plus Ribavirin Combination Therapy
    Tahata, Yuki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Morishita, Naoki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Hosui, Atsushi
    Oshita, Masahide
    Kaneko, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Yamada, Yukinori
    Inada, Masami
    Katayama, Kazuhiro
    Tamura, Shinji
    Imai, Yasuharu
    Hikita, Hayato
    Sakamori, Ryotaro
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (10) : 1776 - 1784
  • [7] Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin
    Wu, Chia-Min
    Su, Fu-Hsiung
    Muo, Chih-Hsin
    Huang, Jou-Chen
    Wu, Meei-Maan
    Yeh, Chih-Ching
    [J]. VIRUSES-BASEL, 2021, 13 (03):
  • [8] Hematological Side Effects of Pegylated Interferon Plus Ribavirin Combination Therapy In Chronic Hepatitis C Treated Patients
    Taseer, Ijaz-Ul-Haque
    Qureshi, Khalid Mahmood
    Mahmood, Muhammad Arif
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2014, 8 (01): : 139 - 141
  • [9] Prognostic factors of chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan
    Chang, C-K
    Tseng, K-C
    Lai, N-S
    Chou, A-L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S73 - S73
  • [10] Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
    Pantazis, Konstantinos D.
    Elefsiniotis, Ioannis S.
    Papaioannou, Dimitrios
    Brokalaki, Hero
    Bonatsos, Gerasimos
    Mavrogiannis, Christos
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2008, 2008